Obstructive and Central Sleep Apnea in First Ever Ischemic Stroke are Associated with Different Time Course and Autonomic Activation.

INTRODUCTION: Sleep-related breathing disorders are highly prevalent in patients with ischemic stroke. Among sleep-disordered breathing disorders, obstructive sleep apnea is the most represented one, but central sleep apnea, isolated or in the context of a periodic breathing/Cheyne-Stokes respiration, is frequently reported in these patients. Altered baroreflex responses have been reported in the acute phases of a cerebral event.
METHODS: We conducted, in a group of patients with ischemic stroke (n=60), a prospective 3-month follow-up physiological study to describe the breathing pattern during sleep and baroreflex sensitivity in the acute phase and in the recovery phase.
RESULTS: In the acute phase, within 10 days from the onset of symptoms, 22.4% of patients had a normal breathing pattern, 40.3% had an obstructive pattern, 16.4% had a central pattern, and 29.9% showed a mixed pattern. Smaller variations in the Apnea-Hypopnea Index were found in normal breathing and obstructive groups (ΔAHI 2.1±4.1 and -2.8±11.6, respectively) in comparison with central and mixed patterns (ΔAHI -6.9±15.1 and -12.5±13.1, respectively; ANOVA p=0.01). The obstructive pattern became the most frequent pattern, in 38.3% of patients at baseline and 61.7% of patients at follow-up. Modification of baroreflex sensitivity over time was influenced by the site of the lesion and by the sleep disorder pattern in the acute phase (MANOVA p=0.005).
CONCLUSION: We suggest that a down-regulation of autonomic activity, possibly related to reduced vagal modulation, may help the recovery after stroke, or a transitory disconnection from the cortical node that participates in the regulation of sympathetic outflow.

Introduction

Sleep-disordered breathing (SDB) and stroke are bidirectionally linked, as obstructive sleep apnea (OSA) is a recognized risk factor for stroke, and, on the other hand, stroke may trigger a new or worsen a pre-existing SDB disorder. Around 50% of patients with stroke suffer from SDB in their acute post-ischemic course. Obstructive sleep apnea (OSA) is certainly the most frequently occurring SDB disorder.1–5 Nevertheless, a clear central breathing component, consisting of a series of central sleep hypopnea/apneas (CSAs), or clustered in periodic breathing/Cheyne–Stokes respiration, is present in 40% of the patients, either alone or mixed with an obstructive component.6 Most of the available literature about the pathophysiological mechanism behind sleep-related central breathing disorders comes from studies on patients with heart failure. A few studies have investigated the putative causal relationship between stroke and CSA.3,6,7 However, the results are still controversial and debated, in particular concerning the size and location of the brain damage that is more prone to cause CSA. Two prospective studies showed that SDB with a central pattern tends to improve spontaneously during the first few months after stroke, suggesting that the acute phase of the cerebrovascular event plays a key role in triggering CSA.7,8 Why and how stroke may induce or worsen a pre-existing central SDB are still unknown. In particular, the roles of baroreflexes and chemoreflexes in the control of breathing during stroke need to be elucidated.

In healthy humans, arterial baroreflex stimulation induced by an increase in arterial blood pressure increases parasympathetic vagal activity and inhibits sympathetic activity. Consequently, the heart rate is reduced, heart contractility is depressed, and total peripheral resistances and venous return fall.9

This regulatory mechanism seems to work also in the acute stage of ischemic cerebral events.9–12 The rationale behind the present study is that in patients with first ever ischemic stroke, the presence of central and/or obstructive sleep-related respiratory events is sustained by two different patterns of autonomic activity. In particular, we postulated the existence of a sustained activation of the sympathetic nervous system in acute stroke, enough to dampen the baroreflex response.

From a clinical viewpoint, CSA in the acute phase of stroke may be the result of an attenuated baroreflex activity, repressed during an emergency. On the other hand, CSA may represent an independent risk factor for ischemic events or a negative factor for stroke outcome. In this context, a baroreflex dysfunction would represent a negative prognostic factor in numerous clinical conditions such as myocardial infarction, heart failure, and stroke.13,14 Sykora et al considered the study of baroreflex in stroke a major challenge in neurophysiology, with a potentially crucial role in new therapeutic strategies.15,16

Aims and Hypothesis

The aims of the present prospective study were:

to assess sleep-related respiratory patterns in the acute and chronic phases of ischemic stroke

to test the baroreflex sensitivity in acute stroke

to verify whether a particular baroreflex response, assessed by the second aim, was related to a specific sleep breathing pattern and to a specific stroke location.

Materials and Methods

An extensive description of the methods is provided in the online .

Subjects

From November 2012 to October 2015, 70 patients with a diagnosis of ischemic stroke were screened according to the following inclusion criteria: age range 18–75 years, ischemic stroke, and hospitalization in a stroke unit within 48 hours from the onset of neurological symptoms. The clinical diagnosis of stroke was established by a neurologist and confirmed by a brain MRI scan in all patients, and the severity was assessed by means of the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale. Patients with pulmonary or cardiocirculatory unstable clinical conditions, patients already on non-invasive mechanical ventilation in the 3 months preceding the stroke, and those with an impaired state of consciousness were excluded.

Sleep Studies

Daytime sleepiness was analyzed by the Epworth Sleepiness Scale (ESS).17 Nocturnal cardiorespiratory monitoring was performed using the ResMed nocturnal polygraphic device Nox T3 (Iceland) within 10 days from stroke onset (median time 3.4±1.4 days), repeated after 3 months, and manually scored according to criteria defined by the American Society of Sleep Medicine.18,19

In the presence of an Apnea–Hypopnea Index (AHI) ≥5, a patient was classified as follows:

dominant central sleep apnea (d-CSA) if ≥70% of the events were scored as central and the central AHI (AHIc) was ≥5

dominant obstructive sleep apnea (d-OSA) if ≥70% of the events were obstructive in nature and the obstructive AHI (AHIo) was ≥5

mixed respiratory pattern (MP) if less than 70% of the events could be scored as obstructive or central, and the global AHI was ≥5.

Patients without respiratory pattern alterations (AHI <5) were classified as having no sleep-disordered breathing (No-SDB).

Pulmonary Function Tests and Autonomic Assessment

At the time of enrollment, all patients underwent a complete lung function test.20 In the acute phase and at the end of follow-up, we obtained an indirect assessment of autonomic regulation of the sinus atrial node.

Cardiac autonomic performance was gauged from baroreflex gain using both, the time domain baroreflex sensitivity (BRS) and the frequency domain index alpha, and heart rate variability. The latter was also assessed by a unitary integrated Autonomic Nervous System Index (ANSI). Individual data points were quantified against a large benchmark population, with values ranging from 0 to 100 (higher values indicating better performance).21,22

Statistical Analysis

Data are presented as mean ± standard deviation. ANOVA was performed to assess differences between the four different patterns of SDB and post-hoc analysis was performed to compare differences between groups. The χ2 test was used to compare the distribution of categorized variables. Pearson’s linear correlation analysis was performed to assess which variables were correlated with sleep respiratory parameters.

The paired t-test was performed to establish changes between baseline and follow-up for all the indices considered. The analysis of variance for repeated measures (MANOVA) was applied to compare changes in AHI or autonomic indices between acute and chronic phase in the four groups of patients according to SDB pattern in the acute phase or site of lesion. Tukey’s honest statistical difference test for unequal sample sizes (Spjotvoll & Stoline test) and the Scheffé test were used to compare differences between groups and within groups, respectively.

Results

Clinical Features

Three out of the 70 screened patients were excluded for technical reasons and seven did not undergo the 3-month follow-up (Figure 1). The characteristics of the remaining 60 patients are reported in Tables 1 and 2.

Figure 1

Flow diagram of the study.

Table 1

Demographic and Clinical Data

	No-SDB (n=15)	d-OSA (n=27)	d-CSA (n=11)	MP (n=14)	Total (n=67)	p
Age (years)	58.1±8.3	62.2±9.9	61.8±7.7	60.2±11.8	60.8±9.6	n.s.
BMI (kg/m2)	23.8±3.4	28.1±4.3	27±3.1	27.6±4.5	26.8±4.2	0.01
NIHSS	0.93±1.2	1.1±2	1.5±2.2	1.3±1.6	1.2±1.8	n.s.
EF (%)	58.7±7.2	60.2±3.7	58.2±6.8	60.7±5.3	59.6±5.5	n.s.
FVC (%)	104.3±18	95.9±20	103.4±15.1	101.5±21.9	100.1±19.3	n.s.
FEV1 (%)	96±19	91±20.7	100.9±14.5	98.9±20.2	95.4±19.7	n.s.
FEV1/FVC	74.4±8.1	76.3±8.6	77.3±7.7	78±6.9	76.4±7.9	n.s.
ESS	7.4±4.7	10±6.3	6.7±3.5	9.1±6.7	8.7±5.7	n.s.
Hypertension (%)	73.3	74.1	81.8	64.3	73.1	n.s.
Diabetes (%)	13.3	25.9	18.2	21.4	20.9	n.s.

Note: Data are presented as mean ± SD unless otherwise indicated.

Abbreviations: BMI, body mass index; NIHSS, NIH Stroke Scale; EF, ejection fraction; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; ESS, Epworth Sleepiness Score; No-SDB, no sleep-disordered breathing; d-OSA, dominant obstructive sleep apnea pattern; d-CSA, dominant central sleep apnea pattern; MP, mixed pattern.

Table 2

Respiratory Polygraphic Indices

	No-SDB (n=15)	d-OSA (n=27)	d-CSA (n=11)	MP (n=14)	Total (n=67)	p
AHI	5.2±2	22.6±14.7	31.9±15.7	27.9±16.9	21.4±16.3	<0.0001
Supine AHI	9.1±4.6	35.1±18.3	43.2±19.3	43.9±22.6	32.7±21.7	<0.0001
AHIo	2.7±1.4	20.6±15.1	4.9±3.9	14.3±9.9	12.8±13	<0.0001
AHIc	2.3±2	2.4±2.9	27.5±15.1	13.4±8.3	8.7±11.6	<0.0001
MCA s	15±3.9	14.6±2.2	17.4±2.7	16.1±2.4	15.5±2.8	n.s.
MOA s	10±8.2	19.3±4.6	16.7±3.4	15.9±3.1	16±6.3	<0.001
Mean SpO2%	93.1±1.7	91.9±1.7	92.2±2.1	91.7±1.5	92.2±1.8	n.s.
SpO2 %nadir	84.9±6.1	78.4±9.2	78.6±5.8	80.2±5.6	80.3±7.7	0.05
Mean amplitude %	3.6±0.4	4.2±0.9	4.2±1.1	4.2±0.8	4.1±0.9	n.s.
ODI	5.6±2.9	22.3±13.3	29.4±15	26.9±16.8	20.7±15.3	<0.001
T90%	8.2±19.4	14.5±16.2	12.6±16.3	13.7±15.7	12.6±16.6	n.s.

Note: Data are presented as mean ± SD.

Abbreviations: AHI, Apnea–Hypopnea Index; AHIo, obstructive AHI; AHIc, central AHI; MCA, mean duration of central apnea; MOA, mean duration of obstructive apnea; Mean SpO2, mean oxygen saturation value; SpO2, nadir minimum oxygen saturation value; Mean amplitude, mean amplitude of desaturation; ODI, oxygen desaturation index; T90, recording time with SpO2 <90%; No-SDB, no sleep-disordered breathing; d-OSA, dominant obstructive sleep apnea pattern; d-CSA, dominant central sleep apnea pattern; MP, mixed pattern.

Forty-nine patients (73%) presented arterial hypertension, whether already treated when hospitalized or newly diagnosed; 52 patients (78%) presented hyperlipidemia, known or newly diagnosed, and 14 patients (21%) had diabetes mellitus. Chronic obstructive pulmonary disease (COPD) was present in 13 patients (19%) (11 stage GOLD I–II, 2 stage GOLD III–IV).

Six patients presented paroxysmal atrial fibrillation during monitoring in the stroke unit but not during ECG recording for baroreflex analysis. One patient had cardiac failure (mean ejection fraction 60%). Forty-eight patients had a supratentorial lesion at MRI, 15 had an infratentorial lesion, and four had supratentorial and infratentorial lesions.

Acute Phase

Clinical and Sleep Data

Fifteen patients (22.4%) had No-SDB, 27 (40.3%) had a d-OSA pattern, 11 (16.4%) had a d-CSA pattern, and 14 (20.9%) showed a mixed pattern (MP). Overall, an AHI >10 was found in 48 patients (71.6%) and an AHI >30 was found in 15 patients (22.4%). Cheyne–Stokes respiration (>10% of total time) was found in 28.3% of patients at baseline: in 12% of patients with a predominant OSA, in 60% of patients with predominant CSA, and in 61.5% of patients with a mixed pattern (χ2<0.001).

Tables 1 and 2 report the clinical and sleep data according to SDB pattern. No significant differences between groups were found in cardiopulmonary function or in the severity of sleep hypoxia. Patients with SDB (any type) had a higher body mass index (BMI) than those without SDB. No association was found between the pattern of SDB and gender, smoking, arterial hypertension, diabetes mellitus, COPD, and obesity. No differences were found between patients with infratentorial or supratentorial lesions in all sleep apnea severity indices. The ischemic damage was localized infratentorially in 33.3% of patients without SDB, in 18.5% of d-OSA, in 18.2% of d-CSA, and in 50% of patients with a mixed pattern (χ2 n.s.).

Age was significantly positively correlated with AHI (r=0.1, p<0.05) and obstructive AHI (r=0.32, p<0.05), but not with central AHI. Similarly, age was negatively correlated with mean SpO2 (r=−0.3, p<0.05) and positively with oxygen desaturation index (ODI) (r=0.3, p<0.05), but was not correlated with recording time with SpO2 <90% (T90). BMI was positively correlated with AHI (r=0.39, p=0.002) and obstructive AHI (r=0.4, p=0.001), but not with central AHI. Finally, AHI and AHIo, but not central AHI, were significantly correlated with forced vital capacity (FVC) (r=−0.31 and −0.35, p<0.05).

Autonomic Data

Neurovegetative data according to SDB pattern and presence/absence of arterial hypertension are reported in Table 3. We found a statistically significantly difference between groups for baroreflex gain as assessed by index alpha BRS and alpha M, accompanied by a clear sympathetic activation in the d-OSA group, independently of the presence of arterial hypertension; a similar trend was found for ANSI, which, however, did not reach the significance level. Of interest, opposite results were found for d-CSA patients without arterial hypertension. Patients with a d-CSA pattern without arterial hypertension showed a significant increase in both BRS and index alpha, suggesting a hyperactivity of the parasympathetic branch of the autonomic system or a suppression of the sympathetic part.

Table 3

Neurovegetative Data Categorized According to SDB Pattern and Presence/Absence of Arterial Hypertension at Baseline

		No-SDB	d-OSA	d-CSA	MP	p
	Hypertension
BRS	No	10.8±7.8	8.4±3.7	25.1±19.9°	8.1±3	<0.01
	Yes	8.3±6.1	5.8±3.9	9.4±6.9°	5.9±3.5
ANSI	No	36.9±30.9	48.4±33.1	87.8±2.8	47.4±41.7	n.s.
	Yes	41.2±25	41.9±31.7	53.8±37.5	39.4±29.6
Alpha M	No	15±7.1	10.3±4.4	32.8±19.2*	7.7±2.8	<0.01
	Yes	8±5.2	10.8±6.9	9.4±5.3*	8.7±3
HR (beats/min)	No	73±5.4	65.7±11	50±5.7	68.9±15.5	n.s.
	Yes	65.6±12.1	66.6±11.4	62.8±13.6	66.3±8.9
RR	No	825±58	937.5±162	1208.4±137.3	905.6±198.2	n.s.
	Yes	943.5±180.5	926±161	992.5±189	919.5±127.6
RR LF/HF	No	2.4±3.3	2.1±3	0.86±0.1	2.6±3.4	n.s.
	Yes	2.1±2.8	3.9±4.6	3.4±7.5	4.7±3.9

Notes: Data are presented as mean ± SD. ° and * Intragroup post-hoc analysis.

Abbreviations: SDB, sleep-disordered breathing; BRS, time domain baroreflex sensitivity; ANSI, Autonomic Nervous System Index; Alpha M, frequency domain baroreflex gain; HR, heart rate; RR, RR interval; LF/HF, ratio of low frequency/high frequency; RR, R-R interval variability spectral power; No-SDB, no sleep-disordered breathing; d-OSA, dominant obstructive sleep apnea pattern; d-CSA, dominant central sleep apnea pattern; MP, mixed pattern.

Moreover, patients with normal ANSI showed higher central AHI (13.5±14.8 vs 5.2±7.8; p=0.009). A significant correlation was found between ANSI and central AHI (r=0.37, p=0.006) but not for obstructive AHI (r=−0.08, p=n.s.). Similarly, the site of stroke seems to influence the baroreflex: BRS was higher in patients with infratentorial stroke (ANOVA p=0.0007), particularly in those without arterial hypertension (Table 4).

Table 4

Neurovegetative Data Categorized According to SDB Pattern and Site of Ischemic Stroke at Baseline

		No-SDB	d-OSA	d-CSA	MP	p
	Site
BRS	Supra	9.4±7.8	6.7±3.9	8.5±6.1°	7.5±3.6	<0.001
	Infra	8.2±3.3	6±4.8	29±14.5°	6.7±3.3
ANSI	Supra	33.5±18.9	44.1±33	54.8±38.3	29.3±21.2	n.s.
	Infra	51.7±33.3	41.9±27.8	83.2±9.3	53.7±38.9
Alpha M	Supra	9.9±7.1	10.8±5.1	9.8±6*	8.1±2.9	0.004
	Infra	9.6±5.5	10.3±10.2	30.6±22.2*	8.4±3
AHI	Supra	5.6±2.3	24.4±15.8	36±14.4	29±16.5	<0.001
	Infra	4.5±1.3	14.8±5	13.8±0.6	27±18.6
AHIo	Supra	2.7±1.2	22.7±16.3	5.7±4.2	13.7±7.5	<0.001
	Infra	2.8±1.9	12.8±4.4	2.4±1.2	14.9±12.5
AHIc	Supra	2.7±2.3	2.5±3.1	32.1±13.8	15.1±9.6	<0.001
	Infra	1.7±1.3	2±2.2	11.2±0.8	11.7±7.1

Note: Data are presented as mean ± SD. ° and * Intragroup post-hoc analysis.

Abbreviations: SDB, sleep-disordered breathing; BRS, time domain baroreflex sensitivity; ANSI, Autonomic Nervous System Index; Alpha M, frequency domain baroreflex gain; AHI, ApnEa–Hypopnea Index; AHIo, obstructive AHI; AHIc, central AHI; No-SDB, no sleep-disordered breathing; d-OSA, dominant obstructive sleep apnea pattern; d-CSA, dominant central sleep apnea pattern; MP, mixed pattern.

Chronic Phase

Seven patients (11.7%) had No-SDB, 37 (61.7%) had a d-OSA pattern, four (6.6%) had a d-CSA pattern, and 12 (20%) showed a mixed pattern (MP). Overall, an AHI >10 was found in 41 patients (68.3%) and an AHI >30 was found in nine patients (15%). Cheyne-Stokes respiration (CSR) was found in 18.2% of patients: in 3.2% of patients with predominant OSA, in 75% of patients with predominant CSA, and in 50% of patients with a mixed pattern (χ2<0.001).

Sleep data are separated for each subgroup of patients classified according to SDB pattern in the acute phase (Table 5): the highest value of AHI was found in patients with a d-CSA pattern.

Table 5

Sleep Data at Follow-Up Categorized According to Baseline SDB Pattern

	No-SDB (n=7)	d-OSA (n=37)	d-CSA (n=4)	MP (n=12)	Total (n=60)	p
Age (years)	58.3±8	62.1±9.7	62±7.7	59.4±11.8	60.7±9.4	n.s.
BMI (kg/m2)	23.6±3.5	27.7±4.8	27.2±2.2	27.5±3.8	26.7±4.2	0.02
ESS						n.s.
AHI	7.2±3.9	21.1±16.3	25.1±15	15.7±11	17.7±14.3	<0.001
AHI supine	17.6±11	37±28.7	36.1±22.5	28±15.5	30.5±22.7	n.s.
AHIo	5.2±3.8	16.8±11.3	14.7±14.1	11.2±10.3	12.4±11.1	0.02
AHIc	2±2.6	1.6±1.5	10.3±9	4.3±2.9	3.9±5.2	<0.0001
MCA s	13.5±2.6	15±3.4	17.6±3.6	14.9±2.7	15.1±2.7	n.s.
MOA s	12.7±10.1	19.4±4.5	20±3.9	16±6.7	17.1±7.1	0.02
Mean SpO2%	92.7±1.4	92.1±1.8	91.4±1.3	91.7±1.9	92±1.7	n.s.
SpO2 nadir %	85.8±5.5	77.5±9.9	80.4±5.3	82.2±5.9	80.8±7.9	0.01
ODI	7.5±4.3	20.7±14.9	25.4±14.2	16.3±11.1	17.7±13.6	<0.01
T90%	4.1±8.7	12.5±13.4	17.5±18.8	15.5±21.8	12.1±16.2	n.s.

Note: Data are presented as mean ± SD unless otherwise indicated.

Abbreviations: SDB, sleep-disordered breathing; BMI, body mass index; ESS, Epworth Sleepiness Score; AHI, ApnEa–Hypopnea Index; AHIo, obstructive AHI; AHIc, central AHI; MCA, mean duration of central apnea; MOA, mean duration of obstructive apnea; Mean SpO2, mean oxygen saturation; SpO2, nadir minimum oxygen saturation value; ODI, oxygen desaturation index; T90, recording time with SpO2 <90%; No-SDB, no sleep-disordered breathing; d-OSA, dominant obstructive sleep apnea pattern; d-CSA, dominant central sleep apnea pattern; MP, mixed pattern.

Global AHI was slightly improved (22.2±16.9 at baseline vs 17.7±14.3 at follow-up, p=0.005). The opposite trend was found for obstructive AHI, which was unchanged (12±11.6 vs 11.8±10.2, respectively; p=n.s.), and for central AHI, that was significantly reduced (9.4±12 vs 4±5.3, respectively; p<0.0001).

Autonomic data separated for each subgroup of patients classified according to SDB pattern in the chronic phase are reported in Table 6.

Table 6

Sleep and Autonomic Data at Follow-Up for Each Group According to Site of Ischemic Stroke and SDB Pattern Observed in the Chronic Phase

		No-SDB	d-OSA	d-CSA	MP	p
	Side
BRS	Supra	11.1±9.4	11.2±10.6	5.9±0.3	8.1±5.1	n.s.
	Infra	13.2±5.6	9.2±9.5	27.2±0.01	61.7±105
Alpha M	Supra	8.6±5.2	13.9±15.1	8±2.8	6.8±4.2	n.s.
	Infra	19.1±16.7	7.7±6	25.6±0.2	18.5±13
AHI	Supra	3.4±1.7	24.4±17.3	24.8±17.6	15.9±8.6	0.02
	Infra	3.2±1.8	12.6±3.3	7.5±0.1	14.9±4.9
AHIo	Supra	2.4±1.3	19.5±13.5	5.5±6.5	9.3±5.5	0.03
	Infra	1±0.9	11.3±3.1	1±0.05	7.6±3.6
AHIc	Supra	0.9±0.6	2.2±2.7	19.3±11.1	6.7±3.5	<0.001
	Infra	2.1±2.7	1.2±1.1	6.5±0.05	6.7±1.9

Note: Data are presented as mean ± SD.

Abbreviations: SDB, sleep-disordered breathing; BRS, time domain baroreflex sensitivity; Alpha M, frequency domain baroreflex gain; AHI, Apnea–Hypopnea Index; AHIo, obstructive AHI; AHIc, central AHI; No-SDB, no sleep-disordered breathing; d-OSA, dominant obstructive sleep apnea pattern; d-CSA, dominant central sleep apnea pattern; MP, mixed pattern; Supra, supratentorial; Infra, infratentorial.

Overall, we found higher values of global, central, and obstructive AHI in patients with supratentorial lesions, regardless of the nature of the SDB pattern (ANCOVA <0.05). A similar pattern was found for ODI (20.1±15.3 in supratentorial vs 12.1±5.2 in infratentorial, p<0.05).

We found higher values of BRS in patients with d-CSA without hypertension in comparison to those with hypertension (27.2±0.01 vs 5.9±0.2, p<0.001). Moreover, in an ANCOVA adjusted for age, we found higher levels of BRS in patients with infratentorial lesion in comparison to those with supratentorial lesion. This difference disappeared in patients with concomitant arterial hypertension.

Changes from Acute to Chronic Phase

Smaller variations in AHI were found in the no-SDB and d-OSA groups (ΔAHI 2.1±4.1 and −2.8±11.6, respectively) in comparison with d-CSA and MP (ΔAHI −6.9±15.1 and −12.5±13.1, respectively) (ANOVA p=0.01). Differences between groups were stronger in obstructive AHI (ANOVA p=0.003), with a significant increase in the d-CSA group (ΔAHIo 11.4±14.6) versus a more stable pattern in the other groups (2.5±3.7 in no-SDB; −2.3±11.2 in d-OSA; −3.1±9.8 in MP).

We observed a marked change in the relative distribution of SDB patterns (χ2=29.6; p<0.0001), as shown in Table 7. Changes were very frequent in d-CSA and MP patients, while those with a d-OSA showed a very stable pattern of SDB. OSA became the most frequent pattern of SDB, seen in 38.3% of patients at baseline and 61.7% of patients at follow-up.

Table 7

Individual Changes in SDB Patterns Between Baseline and Follow-Up

	Follow-Up
Baseline		No-SDB	d-OSA	d-CSA	MP	Totals
	No-SDB	5	6	1	1	13
	d-OSA	1	21	0	1	23
	d-CSA	1	4	2	4	11
	MP	0	6	1	6	13
	Totals	7	37	4	12	60

Abbreviations: SDB, sleep-disordered breathing; No-SDB, no sleep-disordered breathing; d-OSA, dominant obstructive sleep apnea pattern; d-CSA, dominant central sleep apnea pattern; MP, mixed pattern.

Figure 2 reports the changes in the AHI between baseline and follow-up in the four different subgroups classified according to SDB pattern at baseline (MANOVA 3.8; p=0.01), separately for global (A), obstructive (B), and central (C). The greatest decrease in AHI was found in the MP groups (post-hoc p<0.01), while the greatest increase in AHIo was found in the d-CSA groups (post-hoc p<0.05). The AHIc was very stable in the No-SDB and d-OSA groups, and significantly reduced in the d-CSA and MP groups (post-hoc p<0.0001).

Figure 2

Changes in global (A), obstructive (B) and central AHI (C) between acute and chronic phases in the four groups of patients, separately for SDB pattern at baseline.

Overall, no differences were found for BRS and alpha M data between baseline and follow-up according to the baseline or follow-up SDB pattern and presence/absence of arterial hypertension. In contrast, the modification of BRS over time was influenced by the site of the lesion and by the SDB pattern in the acute phase (Figure 3; MANOVA p=0.005). The trend of ANSI was only influenced by the site of lesion (Figure 4; MANOVA p=0.04). Patients with normal ANSI at follow-up showed higher central AHI (5±7.2 vs 2.4±2.5, as observed in the acute phase), close to reaching the significance level (p=0.07).

Figure 3

Modification over time of BRS evaluated according to the site of lesion and the pattern of SDB.

Figure 4

Trend of ANSI between acute and chronic phases according to site of ischemic lesion.

Discussion

The main findings of the present study were: 1) a high prevalence and variability of SDB in the acute phase of cerebral ischemic events that persisted after 3 months; and 2) a different pattern of autonomic activation in obstructive versus central SDB and in supratentorial versus infratentorial lesions.

Previous meta-analyses reported a high variability in the prevalence and heterogeneity of SDB in patients following a transient ischemic attack/stroke. Several factors were hypothesized to explain this heterogeneity. The technical approach to the sleep study was considered the first source of variability: polysomnography (PSG), 8-channel respiratory polygraphy, simplified respiratory monitoring without the possibility to classify the nature of respiratory events, and auto-CPAP devices have been used in previous studies.23 Similarly, the different criteria used in the definition and classification of hypopnea (including the different levels of associated SpO2 drops) is another important source of variability. As a consequence, the dominant pattern of SDB in each patient was attributed according to the apnea index. However, looking at the largest studies (number of patients >100), we can easily recognize that the most prevalent respiratory events were hypopneas.23 According to the American Academy of Sleep Medicine criteria, we have classified all the respiratory events, including hypopneas, in order to define for each patient the prevalent pattern of SDB. We are aware that the 70% threshold that we have chosen to classify patients is arbitrary, but we preferred to adopt a higher cut-off than usual to be sure to identify the “true” central pattern. By using this threshold, the results allowed a clear physiological differentiation of each group of patients. Indeed, using the usual 50% threshold to classify the patients, we found a clear overlap between patients with prevalent OSA and CSA. These results are available as supplemental material in and –.

The prevalence of SDB in the present study was very high, in both the acute and chronic phases. Differently from previous studies, we did not find a significantly spontaneous improvement over time.1,3,23,24 In particular, only 38% of patients classified as no-SDB at baseline still had the same pattern at follow-up: 46.1% developed a d-OSA and the remaining patients a d-CSA or mixed pattern.

OSA remains the most frequent SDB type, especially in the chronic phase, but with a lower prevalence than previously reported.4 In contrast, we found a higher prevalence of CSA or mixed pattern: the prevalence of CSA in the acute phase has been estimated to be 7% in a recent meta-analysis23 and as 2.2% in another study.5 The mixed pattern was not previously detected owing to the absence of specific criteria to discriminate between obstructive and central hypopneas. Central events did not correlate with common anthropometric determinants of OSA such as age, BMI, and lung volumes, suggesting a different physiological mechanism. Indeed, modifications in SDB pattern and severity were found between baseline and follow-up evaluation, especially in patients with a baseline d-CSA or mixed pattern. Most of these developed a d-OSA pattern at follow-up, suggesting the pre-existence of OSA before the stroke.

The presence of sympathetic overactivity in OSA patients was recognized many years ago.25 Similar findings were found in the present study in the d-OSA group and/or in patients with arterial hypertension. It is well known that repetitive episodes of intermittent hypoxia promote hyperventilation, vasoconstriction to redistribute blood flow to vital organs, and bradycardia to reduce myocardial oxygen demand.26 Impairment in baroreceptor sensitivity has been reported in patients with acute ischemic stroke and has been associated with increased long-term mortality.13 However, the presence of arterial hypertension and sleep apnea was not previously considered. Similar data were reported by Sykora et al15 for patients with acute intracerebral hemorrhage and more recently by Webb et al.14

The pathophysiological mechanisms of reduced baroreceptor sensitivity in patients with stroke are not known. Several hypotheses have been suggested: 1) the site of the lesion,9,10,26 2) the coexistence of arterial hypertension,27 3) the presence of bilateral carotid atherosclerosis,12,28 and 4) the presence of SDB.29,30 Accordingly, in the present study, three different factors were individually and mutually associated with reduced baroreflex gain, in the acute as well as in the chronic phase: 1) arterial hypertension, 2) d-OSA pattern, and 3) supratentorial site of lesion. Our results concur with those published by Taylor et al, where a thinning of the left dorsal posterior insula (ldpIC), the vasodepressor region, was reported in patients with moderate to severe OSA: the severity of nocturnal hypoxia was inversely correlated with the thickness of the ldpIC.30 In the same study, the authors found an increase in gray matter thickness or density in the left mid-cingulate cortex in the region of the left posterior thalamus, probably related to a chronically augmented chemoreceptor input due to repetitive episodes of asphyxia and intermittent hypoxia.30,31 On the other hand, Spicuzza et al reported a different autonomic heart-rate modulation during obstructive versus central apneas in patients with sleep apnea: apart from obstructive events, during central apnea episodes, the respiratory component of R-R interval variability is nearly absent during the apneic phase and recovers with the resumption of ventilation.32 They concluded that the autonomic changes, initiated by an obstructive event, may last into the post-apneic phase, whereas the changes induced by the central events passively reflect the changes in ventilation.

Baroreflex sensitivity is usually reduced during exercise in healthy individuals, and it is reduced in the upright versus supine position.33,34 The latter condition is characterized by predominant sympathetic modulation; the former implies possible suppression of vagal activity.35–38 Therefore, it is tempting to suggest that the autonomic changes observed in the present study may be related to a reduction, if not a suppression, of autonomic modulation of the heart in stroke-related SDB.

Up to now, studies designed to assess the mutual relationship between lesion location and type or severity of SDB have given mixed and inconclusive results.8 We found a solid relationship between a d-CSA pattern and an infratentorial lesion. These patients showed higher indices of baroreflex gain and ANSI values, and changes in baroreflex over time were influenced by the site of lesion and by the pattern of SDB: BRS improved only in d-CSA patients with an infratentorial lesion.

The design of the present study did not permit the identification of the pathophysiological mechanisms of this finding. In the acute phase after the stroke, all the circuits that regulate the breathing pattern as well as autonomic outflow may be blunted.30 Transitory loss of information from peripheral chemoreceptors or lung receptors, or a loss of connections inside the central autonomic network may explain 1) the shift of central autonomic regulation to an inhibitory prevalence in patients with d-CSA without arterial hypertension and 2) the reduced ventilatory drive that we indirectly observed in these patients: baseline carbon dioxide was higher in patients with d-CSA or mixed pattern in comparison to that with d-OSA. On the other hand, it has been demonstrated that slow breathing enhances baroreflex sensitivity without inducing hyperventilation.39 Similarly, Lorenzi-Filho et al demonstrated that periodic breathing with central apneas entrains blood pressure and heart rate and increases the magnitude of their oscillations in healthy subjects.40

Conclusion

The present results suggest a down-regulation of autonomic activity, possibly related to reduced vagal modulation, that may sustain the recovery after stroke, or a transitory disconnection from the cortical node that participates in the regulation of sympathetic outflow, altering the excitatory–inhibitory balance.

The enrollment of relatively young patients with mild to moderate stroke severity gave us the possibility to explore some physiological insights that would otherwise not be detectable in patients with severe lesions. However, larger multicentric studies, ideally extended to patients with hemorrhagic and large and severe brain ischemic damage, are necessary to confirm the main findings of the present study: preserved baroreflex sensitivity was found only in those patients with concomitant infratentorial lesion, d-CSA pattern and absence of peripheral arterial hypertension. Determining the exact physiological mechanisms that link these three factors should be aim of future investigations.

A clear limitation of this study is the arbitrariness of the cut-off that we chose to classify patients in the obstructive, central or mixed pattern. We chose to classify all respiratory events, apneas and hypopneas, according to the standard criteria and we identified a 70% cut-off as a threshold to discriminate the different respiratory patterns potentially expressing different underlying pathophysiological mechanisms. However, we recognize the need for a methodological study to define the future appropriate method for the classification of SDB patterns in specific categories of patients (ie, stroke, heart failure) where mixed patterns are very common.

Finally, the methods used did not allow us to explore a pre-existing form of SDB before stroke, and this is certainly a further limit of the present study.